Feeds:
Posts
Comments

Posts Tagged ‘Science Daily’

SCIENCE DAILY: A combination of radiation therapy and chemotherapy given before prostate removal is safe and may have the potential to reduce cancer recurrence and improve patient survival. READ MORE>

Read Full Post »

SCIENCE DAILY: The size and shape of the blood vessels visible within a prostate cancer tumour may be a useful clue to how the cancer will behave and how it needs to be treated. READ MORE>

A diagnosis of prostate cancer raises the question for patients and their physicians as to how the tumour will behave.

Will it grow quickly and aggressively and require continuous treatment, or slowly, allowing therapy and its risks to be safely delayed?

The answer may lie in the size and shape of the blood vessels that are visible within the cancer.

Read Full Post »

SCIENCE DAILY: Researchers have destroyed prostate cancer tumors in mice by injecting them with specially-coated, miniscule carbon tubes and then superheating the tubes with a brief zap of a laser. READ MORE>

Read Full Post »

JULY 30: SCIENCE DAILY: A team of scientists has developed a computer model that predicts cancer recurrence in an individual based on how the tumour changes size in response to the first rounds of radiation therapy. READ MORE>

Read Full Post »

JUNE 11: SCIENCE DAILY: A new system offers the possibility of measuring the absorbed dose in the direct environment of an irradiated tumour. READ MORE>

Read Full Post »

MAY 24: SCIENCE DAILY:  A phase I clinical trial of a herb-based therapeutic called Zyflamend has shown the therapy has minimal toxicity and no serious adverse events in men at high risk for developing prostate cancer. READ MORE>

Read Full Post »

MAY 15: SCIENCE DAILY: A ground-breaking Canada-wide clinical trial has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of cancer patients, including prostate. The study demonstrates that ribavirin suppresses the activities of the eIF4E gene in patients. This gene is dysregulated in 30 percent of cancers including breast, prostate, head and neck, colon and stomach cancer. READ MORE>

Read Full Post »

Older Posts »